BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 36672316)

  • 1. Turning Tertiary Lymphoid Structures (TLS) into Hot Spots: Values of TLS in Gastrointestinal Tumors.
    Cai D; Yu H; Wang X; Mao Y; Liang M; Lu X; Shen X; Guan W
    Cancers (Basel); 2023 Jan; 15(2):. PubMed ID: 36672316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insights into tertiary lymphoid structures in the solid tumor microenvironment: anti-tumor mechanism, functional regulation, and immunotherapeutic strategies.
    Zhao H; Wang H; Zhou Q; Ren X
    Cancer Biol Med; 2021 Sep; 18(4):981-91. PubMed ID: 34553849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tertiary lymphoid structures as unique constructions associated with the organization, education, and function of tumor-infiltrating immunocytes.
    Chen J; Chen J; Wang L
    J Zhejiang Univ Sci B; 2022 Oct; 23(10):812-822. PubMed ID: 36226536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tertiary lymphoid structure patterns aid in identification of tumor microenvironment infiltration and selection of therapeutic agents in bladder cancer.
    An Y; Sun JX; Xu MY; Xu JZ; Ma SY; Liu CQ; Liu Z; Wang SG; Xia QD
    Front Immunol; 2022; 13():1049884. PubMed ID: 36420257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tertiary lymphoid structures in pancreatic cancer: a new target for immunotherapy.
    Zou X; Guan C; Gao J; Shi W; Cui Y; Zhong X
    Front Immunol; 2023; 14():1222719. PubMed ID: 37529035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intratumoral tertiary lymphoid structures promote patient survival and immunotherapy response in head neck squamous cell carcinoma.
    Liu Z; Meng X; Tang X; Zou W; He Y
    Cancer Immunol Immunother; 2023 Jun; 72(6):1505-1521. PubMed ID: 36481914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor immune microenvironment of cutaneous angiosarcoma with cancer testis antigens and the formation of tertiary lymphoid structures.
    Magara T; Nakamura M; Nojiri Y; Yoshimitsu M; Kano S; Kato H; Morita A
    Front Oncol; 2023; 13():1106434. PubMed ID: 37081973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Presence of Tertiary Lymphoid Structures Provides New Insight Into the Clinicopathological Features and Prognosis of Patients With Breast Cancer.
    Wang B; Liu J; Han Y; Deng Y; Li J; Jiang Y
    Front Immunol; 2022; 13():868155. PubMed ID: 35664009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical relevance of tertiary lymphoid structures in esophageal squamous cell carcinoma.
    Deguchi S; Tanaka H; Suzuki S; Natsuki S; Mori T; Miki Y; Yoshii M; Tamura T; Toyokawa T; Lee S; Muguruma K; Wanibuchi H; Ohira M
    BMC Cancer; 2022 Jun; 22(1):699. PubMed ID: 35751038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preventive effect of tertiary lymphoid structures on lymph node metastasis of lung adenocarcinoma.
    Wakasu S; Tagawa T; Haratake N; Kinoshita F; Oku Y; Ono Y; Takenaka T; Oda Y; Shimokawa M; Mori M
    Cancer Immunol Immunother; 2023 Jun; 72(6):1823-1834. PubMed ID: 36688996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intra-tumoral tertiary lymphoid structures are associated with a low risk of early recurrence of hepatocellular carcinoma.
    Calderaro J; Petitprez F; Becht E; Laurent A; Hirsch TZ; Rousseau B; Luciani A; Amaddeo G; Derman J; Charpy C; Zucman-Rossi J; Fridman WH; Sautès-Fridman C
    J Hepatol; 2019 Jan; 70(1):58-65. PubMed ID: 30213589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tertiary Lymphoid Structures Are Associated with a Favorable Prognosis in High-Grade Serous Ovarian Cancer Patients.
    Zhang K; Xie X; Zou LH; Guo SQ
    Reprod Sci; 2023 Aug; 30(8):2468-2480. PubMed ID: 36759495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unique characteristics of tertiary lymphoid structures in kidney clear cell carcinoma: prognostic outcome and comparison with bladder cancer.
    Masuda T; Tanaka N; Takamatsu K; Hakozaki K; Takahashi R; Anno T; Kufukihara R; Shojo K; Mikami S; Shinojima T; Kakimi K; Tsunoda T; Aimono E; Nishihara H; Mizuno R; Oya M
    J Immunother Cancer; 2022 Mar; 10(3):. PubMed ID: 35314433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tertiary lymphoid structures in the era of cancer immunotherapy.
    Sautès-Fridman C; Petitprez F; Calderaro J; Fridman WH
    Nat Rev Cancer; 2019 Jun; 19(6):307-325. PubMed ID: 31092904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tertiary lymphoid structures are critical for cancer prognosis and therapeutic response.
    Zhang Q; Wu S
    Front Immunol; 2022; 13():1063711. PubMed ID: 36713409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tertiary lymphoid structures in cancer: immune mechanisms and clinical implications.
    Wang S; Wang H; Li C; Liu B; He S; Tu C
    MedComm (2020); 2024 Mar; 5(3):e489. PubMed ID: 38469550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Density and maturity of peritumoral tertiary lymphoid structures in oesophageal squamous cell carcinoma predicts patient survival and response to immune checkpoint inhibitors.
    Hayashi Y; Makino T; Sato E; Ohshima K; Nogi Y; Kanemura T; Honma K; Yamashita K; Saito T; Tanaka K; Yamamoto K; Takahashi T; Kurokawa Y; Miyata H; Nakajima K; Wada H; Morii E; Eguchi H; Doki Y
    Br J Cancer; 2023 Jun; 128(12):2175-2185. PubMed ID: 37016103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infiltrating characteristics and prognostic value of tertiary lymphoid structures in resected gastric neuroendocrine neoplasm patients.
    Cai D; Wang X; Yu H; Bai C; Mao Y; Liang M; Xia X; Liu S; Wang M; Lu X; Du J; Shen X; Guan W
    Clin Transl Immunology; 2024; 13(2):e1489. PubMed ID: 38322490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Follicle-like tertiary lymphoid structures: A potential biomarker for prognosis and immunotherapy response in patients with laryngeal squamous cell carcinoma.
    Liang H; Zhang Z; Guan Z; Zheng S; Lou J; Liu W; Cai Q; Si Y
    Front Immunol; 2023; 14():1096220. PubMed ID: 36776859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peritumoral tertiary lymphoid structure and tumor stroma percentage predict the prognosis of patients with non-metastatic colorectal cancer.
    Wang Q; Shen X; An R; Bai J; Dong J; Cai H; Zhu H; Zhong W; Chen W; Liu A; Du J
    Front Immunol; 2022; 13():962056. PubMed ID: 36189233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.